↓ Skip to main content

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective…

Overview of attention for article published in Cancer Immunology, Immunotherapy, May 2008
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
66 Mendeley
Title
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
Published in
Cancer Immunology, Immunotherapy, May 2008
DOI 10.1007/s00262-008-0526-1
Pubmed ID
Authors

T. Schulze, W. Kemmner, J. Weitz, K.-D. Wernecke, V. Schirrmacher, P. M. Schlag

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 2%
United States 1 2%
Canada 1 2%
Unknown 63 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 21%
Researcher 11 17%
Student > Master 7 11%
Student > Bachelor 6 9%
Student > Doctoral Student 4 6%
Other 11 17%
Unknown 13 20%
Readers by discipline Count As %
Medicine and Dentistry 19 29%
Agricultural and Biological Sciences 11 17%
Biochemistry, Genetics and Molecular Biology 10 15%
Immunology and Microbiology 3 5%
Unspecified 2 3%
Other 7 11%
Unknown 14 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2024.
All research outputs
#20,661,397
of 25,388,229 outputs
Outputs from Cancer Immunology, Immunotherapy
#2,568
of 2,982 outputs
Outputs of similar age
#89,349
of 96,403 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#21
of 22 outputs
Altmetric has tracked 25,388,229 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,982 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,403 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.